Impaired radial artery compliance in normotensive subjects with familial hypercholesterolemia

Atherosclerosis

Volumn 124, Issue 2, 1996, Pages 249-260

  Giannattasio, Cristina ^a   Mangoni, Arduino A ^b   Failla, Monica ^a   Carugo, Stefano ^b   Stella, Maria Luisa ^b   Stefanoni, Patrizia ^a   Grassi, Guido ^b   Vergani, Carlo ^a   Mancia, Giuseppe ^a,b,c,d  

^a UNIVERSITY OF MILAN   (Italy)

^b Ctr Fisiol Clin/Ipertensione   (Italy)

^c ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^d SAN GERARDO HOSPITAL   (Italy)

Author keywords

Arterial compliance; Familial hypercholesterolemia; Lipid profile; Peripheral circulation

Indexed keywords

ANTILIPEMIC AGENT; SIMVASTATIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; ORAL DRUG ADMINISTRATION; PERIPHERAL CIRCULATION; PRIORITY JOURNAL;

EID: 0030564977     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05834-0     Document Type: Article

References (41)

1. [1] Creager M, Cooke JP, Mendelson ME. Gallagher SJ, Coleman SM. Loscalzo J, Dzau VJ. Impaired vasodilatation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990;86:228-234.
2. [2] Chowienczyk PJ, Watts GF, Cockcroft JR, Ritte JM. Impaired endothelium-dependent vasodilatation of forearm resistance vessels in hypercholesterolemia. Lancet 1992;340:1430-1432.
3. [3] Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, Panza JA. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation 1993;88:2541-2547.
4. [4] Zelis R, Mason DT, Braunwald E, Levy RI. Effects of hyperlypoproteinemias and their treatment on the peripheral circulation. J Clin Invest 1970;49:1007-1015.
5. [5] Drexler H, Zeiher AM. Endothelial function in human coronary arteries in vivo: focus on hypercholesterolemia. Hypertension 1991;18(II):II90-II99.
6. [6] Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different stages of coronary atherosclerosis. Circulation 1991;83:391-401.
7. [7] Ross R. The pathogenesis of atherosclerosis. An update. New Engl J Med 1986;314:488-500.
8. [8] Booth RFG, Martin JF, Honey AC, Hassal DG, Beesley JE, Moncada S. Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. Atherosclerosis 1989;76:257-268.
9. [9] Brown MS, Goldstein JL. Familial hypercholesterolemia: genetic, biochemical and pathophysiological considerations. Adv Intern Med 1979;20:273-276.
10. [10] Tardy Y, Meister JJ, Perret F, Brunner HR, Arditi M. Non invasive estimate of the mechanical properties of peripheral arteries from ultrasonic and photoplethysmographic measurements. Clin Phys Physiol Meas 1991;3:360-367.
11. [11] Parati G, Casadei R, Groppelli A, Di Rienzo M, Mancia G. Comparison of finger intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension 1989;13:647-655.
12. [12] Imholz BP, Van Montfrans GA. Settels JJ, Van der Hoeven GM, Karemaker JM, Wieling W. Continuous non-invasive blood pressure monitoring: reliability of Finapres device during the Valsalva maneuvre. Cardiovasc Res 1988;22(6):390-397.
13. [13] Langewouters GJ, Zwart A, Busse R, Wesseling KH. Pressure diameter relationship of segments of human finger arteries. Clin Phys Physiol Meas 1986;7:43-45.
14. [14] Giannattasio C, Mangoni AA, Stella ML, Carugo S, Grassi G, Mancia G. Acute effects of smoking on radial artery compliance in humans. J Hypertens 1994;12:691-696.
15. [15] Giannattasio C, Cattaneo BM, Mangoni AA, Carugo S, Failla M, Trazzi S, Sega R, Grassi G, Mancia G. Cardiac and vascular structural changes in normotensive subjects with parental hypertension. J Hypertens 1995;13(2):259-264.
16. [16] Giannattasio C, Failla M, Stella ML, Mangoni AA, Carugo S, Pozzi M, Grassi G, Mancia G. Alterations in radial artery compliance in patients with congestive heart failure. Am J Cardiol 1995;76:381-385.
17. [17] Hayoz D, Drexler H, Munsen T, Harnig B, Zeiler AH, Just H, Brunner HR, Zelis R. Flow-mediated arterial dilation is abnormal in congestive heart failure. Circulation 1993;87(7):VII-92-VII-96.
18. [18] Folkow B, Grimby G, Thulesius O. Adaptive structural changes of the vascular walls in hypertension and their relations to the control of peripheral resistance. Acta Physiol Scand 1958;44:225-272.
19. [19] Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;299:373-376.
20. [20] Scott-Burden T, Resink TJ, Hann AWA, Baur U, Box RJ, Bunler FR. Induction of growth-related metabolism in human vascular smooth muscle cells by low-density lipoprotein. J Biol Chem 1989;264:12582-12589.
21. [21] Ross R, Glomset J. Atherosclerosis and the arterial muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science 1973;180:1332-1339.
22. [22] Genest JJ Jr, Martin-Munley SS, McNamara JR, Ordovas JM, Jenner J, Myers RH, Silberman SR, Wilson P, Salam DN, Schaefer EJ. Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 1992;85(6):2025-2033.
23. [23] Andrews HE, Bruckdorfer KR, Dunn RC, Jacops M. Low density lipoproteins inhibit endothelial dependent relaxation in rabbit aorta. Nature 1987;3278:237-239.
24. [24] Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent relaxation by lysolecithin in modified low-density lipoproteins. Nature 1990;344:160-162.
25. [25] Matsuda Y, Hirata K, Inoue N, Suematsu M. Kawashima S, Akita H, Yokoyama M. High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation. Circ Res 1993;72:1103-1109.
26. [26] McLenachan JM, Williams JK, Fish RD, Ganz P, Selwyn AP. Loss of flow-mediated endothelium-dependent dilatation occurs early in the development of atherosclerosis. Circulation 1991;84:1273-1278.
27. [27] Skinner SN. Skeletal Muscle Blood Flow. Metabolic determinants. In Zelis R, (ed.). The Peripheral Circulation. New York: Grune Stratton 1975:57-78.
28. [28] Brown G, Albers JJ, Fischer LD. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. New Engl J Med 1990;323:1289-1298.
29. [29] Bissett JK, Wyeth RP, Matts JP, Johnson JW. Plasma lipid concentrations and subsequent coronary occlusion after a first myocardial infarction. The POSCH Group. Am J Med Sci 1993;305 (3):139-144.
30. [30] Koga N, Iwata Y. Pathological and angiographic regression of coronary atherosclerosis by LDL-apheresis in a patient with familial hypercholesterolemia. Atherosclerosis 1991;90(1):9-21.
31. [31] Brown BG, Lin JT, Passamani ER, Levy RI, Dodge HT, Detre KM. Progression of coronary atherosclerosis in patients with probable familial hypercholesterolemia. Quantitative arteriographic assessment of patients in NHLBI type II study. Arteriosclerosis 1989;9(1):181-190.
32. [32] Egashira K, Hirooka Y, Kai H, Sugimachi M, Suzuchi M, Inou T, Takeshita A. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 1994;89:2519-2524.
33. [33] McGill HC Jr. The Geographic Pathology of Atherosclerosis. Baltimore: Williams and Wilkins, 1968.
34. [34] Riley WA, Freedman DS, Higgs NA, Barnes RW, Zinkgraf SA, Berenson GS. Decreased arterial elasticity associated with cardiovascular disease risk factors in the young. Bogalousa HART study. Arteriosclerosis 1986;6:378-386.
35. [35] Lehmann ED, Watts GF, Fatemi-Langroudi B, Gousling RG. Aortic compliance in young patients with heterozygous familial hypercholesterolemia. Clin Sci 1982;83:717-721.
36. [36] Wendelhag I, Wilkund O, Wilkstrand J. Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia. Ultrasonographic assessment of intima-media thickness and plaque occurrence. Atheroscler Thromb 1993;13:1404-1410.
37. [37] Gariepy J, Simon A, Massonreau M, Linhart A, Levenson J. Wall thickening of carotid and femoral arteries in male subjects with isolated hypercholesterolemia. Atherosclerosis 1995;113:141-151.
38. [38] Forstermann U, Mugge A, Alheid U, Haverich A, Frolich JC. Selective attenuation of endothelium-mediated vasodilatation in atherosclerotic human coronary arteries. Circ Res 1988;62:185-190.
39. [39] Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. New Engl J Med 1986;315:1046-1051.
40. [40] Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekstein VI, Selwyn AP, Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary heart disease. Circulation 1990;81:491-497.
41. [41] O'Rourke MF. Arterial function in health and disease. Edinburgh: Churchill Livingstone, 1982.